Neuro-cognitive (HVLT-R total recall) functioning in localized vs. metastatic small-cell lung cancer with or without hippocampus sparing PCI: Results from a phase III trial

J. van Meerbeeck (Edegem, Belgium), D. De Ruysscher (Maastricht, Netherlands), J. Belderbos (Amsterdam, Netherlands), K. De Jaeger (Eindhoven, Netherlands), F. Koppe (Tilburg, Netherlands), M. Lambrechts (Leuven, Belgium), Y. Lievens (Ghent, Belgium), E. Dieleman (Amsterdam, Netherlands), J. Jaspers (Rotterdam, Netherlands), J. Ubbels (Groningen, Netherlands), M. Kwint (Maastricht, Netherlands), M. Kuenen (Amsterdam, Netherlands), S. Deprez (Leuven, Belgium), M. De Ruiter (Amsterdam, Netherlands), K. Sikorska (Amsterdam, Netherlands), H. Van Tinteren (Amsterdam, Netherlands), S. Schagen (Amsterdam, Netherlands)

Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Session: Brain Metastasis and Malignant pleural effusion: improving our understanding
Session type: Oral Presentation
Number: 5103
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van Meerbeeck (Edegem, Belgium), D. De Ruysscher (Maastricht, Netherlands), J. Belderbos (Amsterdam, Netherlands), K. De Jaeger (Eindhoven, Netherlands), F. Koppe (Tilburg, Netherlands), M. Lambrechts (Leuven, Belgium), Y. Lievens (Ghent, Belgium), E. Dieleman (Amsterdam, Netherlands), J. Jaspers (Rotterdam, Netherlands), J. Ubbels (Groningen, Netherlands), M. Kwint (Maastricht, Netherlands), M. Kuenen (Amsterdam, Netherlands), S. Deprez (Leuven, Belgium), M. De Ruiter (Amsterdam, Netherlands), K. Sikorska (Amsterdam, Netherlands), H. Van Tinteren (Amsterdam, Netherlands), S. Schagen (Amsterdam, Netherlands). Neuro-cognitive (HVLT-R total recall) functioning in localized vs. metastatic small-cell lung cancer with or without hippocampus sparing PCI: Results from a phase III trial. 5103

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: